<DOC>
	<DOCNO>NCT02380196</DOCNO>
	<brief_summary>The primary objective study determine whether circulate tumor cell ( CTCs ) use non-invasive mean confirm pathologic diagnosis early-stage ( Stage I ) non-small cell lung cancer ( NSCLC ) . Patients schedule undergo surgical intervention blood sample obtain test CTCs . Presence CTCs compare final pathologic diagnosis base surgical specimen assess sensitivity use CTCs alone make definitive diagnosis .</brief_summary>
	<brief_title>The Utility Circulating Tumor Cells Confirmation Pathologic Diagnosis Patients With Suspected Early Stage Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>1 . Clinical diagnosis stage I NSCLC . Only patient pathologically confirm NSCLC retain data analysis b . Should pathologic diagnosis reveal advanced stage , subject remain study 2 . 18 year age 3 . Ability read sign inform consent 4 . Both men woman member race ethnic group eligible trial . 1 . Prior cancer diagnosis , exclude previously treat nonmelanoma skin cancer 2 . Prior ongoing treatment clinically diagnose cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>